Stephen Kelsey sold 5,447 shares — Revolution Medicines (NASDAQ: RVMD)

Rhea-AI Filing Summary

Stephen Michael Kelsey reported a proposed/recorded sale of 5,447 shares of Common Stock on 12/16/2025 for $418,423.29. The filing also lists restricted stock unit grants dated 03/01/2022, 03/01/2023, 03/01/2024, and 03/01/2025 with counts 910, 937, 1,193, and 861, respectively.

Insights

Equity Compensation Lawyer

Routine insider disposition under securities rules; compensation grants also listed.

The filing documents a reported sale of 5,447 shares on 12/16/2025 for $418,423.29. This is presented as a Form 144 notification of a proposed sale by an affiliated person.

The filing lists restricted stock unit grants from 03/01/2022 to 03/01/2025 with specific share counts; these grant counts are recorded items in the notice.

Corporate Governance Analyst

Disclosure is routine and informational; no material corporate action disclosed.

The filing identifies the reporting person and the sale amount, and records prior RSU grant quantities. There is no statement of corporate proceeds or new corporate actions in the excerpt.

Subsequent filings or market disclosures would be required to show any broader corporate impact.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common Stock	ETRADE Financial Corporation 3 Edison Drive Alpharetta GA 30005	3901	388500.59	198173397	03/16/2026	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common Stock	03/01/2022	Restricted stock unit grant	Issuer			910	03/01/2022	Services rendered
Common Stock	03/01/2023	Restricted stock unit grant	Issuer			937	03/01/2023	Services rendered
Common Stock	03/01/2024	Restricted stock unit grant	Issuer			1193	03/01/2024	Services rendered
Common Stock	03/01/2025	Restricted stock unit grant	Issuer			861	03/01/2025	Services rendered

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
Stephen Michael Kelsey c/o Revolution Medicines, Inc. 700 Saginaw Drive Redwood City CA 94063	Common Stock	12/16/2025	5447	418423.29

144: Remarks and Signature

Remarks

Date of Notice

Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What did the Form 144 for RVMD report?

The Form 144 reports a sale of 5,447 Revolution Medicines shares on 12/16/2025 for $418,423.29. It also lists several restricted stock unit grants dated 03/01/2022–03/01/2025 with specific share counts.

Who is the reporting person in the RVMD Form 144?

The reporting person is Stephen Michael Kelsey, listed c/o Revolution Medicines, Inc. The filing associates him with the reported sale of 5,447 common shares on 12/16/2025.

Which restricted stock unit grants are listed in the filing?

The filing lists RSU grants dated 03/01/2022 (910 shares), 03/01/2023 (937 shares), 03/01/2024 (1,193 shares), and 03/01/2025 (861 shares). These amounts appear as listed securities in the notice.

Does the Form 144 state who receives sale proceeds?

The excerpt provides the sale price $418,423.29 tied to the 12/16/2025 sale, but it does not specify the recipient of proceeds or any corporate use of proceeds in the provided text.

Is this Form 144 a material corporate disclosure for RVMD?

This Form 144 is a regulatory notice of an insider disposition (5,447 shares) and lists RSU grants; the excerpt does not disclose any material corporate events or changes to company operations.